An Update on the Experimental Drug Alpharadin
Alpharadin Update Men whose prostate cancer has metastasized to the bone may have access to a new drug treatment that helps significantly extend their life by mid-year 2012. In August, the U.S. Food and Drug Administration agreed to fast-track Alpharadin based on the drug’s performance in a Phase III study. The... Read more


